WO2009116074A3 - Substituted benzimidazoles as cannabinoid modulator - Google Patents
Substituted benzimidazoles as cannabinoid modulator Download PDFInfo
- Publication number
- WO2009116074A3 WO2009116074A3 PCT/IN2009/000099 IN2009000099W WO2009116074A3 WO 2009116074 A3 WO2009116074 A3 WO 2009116074A3 IN 2009000099 W IN2009000099 W IN 2009000099W WO 2009116074 A3 WO2009116074 A3 WO 2009116074A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutically acceptable
- substituted benzimidazoles
- regioisomers
- stereoisomers
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to novel compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing novel compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN313/MUM/2008 | 2008-02-13 | ||
IN313MU2008 | 2008-02-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009116074A2 WO2009116074A2 (en) | 2009-09-24 |
WO2009116074A3 true WO2009116074A3 (en) | 2009-11-12 |
Family
ID=41057444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2009/000099 WO2009116074A2 (en) | 2008-02-13 | 2009-02-12 | Substituted benzimidazoles as cannabinoid modulator |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009116074A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2536285B1 (en) | 2010-02-18 | 2018-04-25 | vTv Therapeutics LLC | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
PE20170143A1 (en) | 2014-02-11 | 2017-03-19 | Bayer Pharma AG | BENZIMIDAZOLE-2-AMINES AS MIDH1 INHIBITORS |
ES2732902T3 (en) | 2014-02-11 | 2019-11-26 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Benzimidazol-2-amines as MIDH1 inhibitors |
ES2814151T3 (en) | 2014-10-23 | 2021-03-26 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | 1-Cyclohexyl-2-phenylaminobenzimidazoles as MIDH1 inhibitors for the treatment of tumors |
US10138226B2 (en) | 2014-10-23 | 2018-11-27 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as MIDH1 inhibitors |
WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
WO2016198322A1 (en) | 2015-06-08 | 2016-12-15 | Bayer Pharma Aktiengesellschaft | N-menthylbenzimidazoles as midh1 inhibitors |
US10414734B2 (en) | 2015-07-16 | 2019-09-17 | Bayer Pharma Aktiengesellschaft | 5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors |
ES2899114T3 (en) * | 2016-07-25 | 2022-03-10 | Nerviano Medical Sciences Srl | Purine and 3-deazapurine analogs as choline kinase inhibitors |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002085866A1 (en) * | 2001-04-20 | 2002-10-31 | Astrazeneca Ab | Novel compounds |
WO2008153701A1 (en) * | 2007-05-24 | 2008-12-18 | Schering Corporation | Compounds for inhibiting ksp kinesin activity |
-
2009
- 2009-02-12 WO PCT/IN2009/000099 patent/WO2009116074A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002085866A1 (en) * | 2001-04-20 | 2002-10-31 | Astrazeneca Ab | Novel compounds |
WO2008153701A1 (en) * | 2007-05-24 | 2008-12-18 | Schering Corporation | Compounds for inhibiting ksp kinesin activity |
Also Published As
Publication number | Publication date |
---|---|
WO2009116074A2 (en) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009116074A3 (en) | Substituted benzimidazoles as cannabinoid modulator | |
PH12015501199B1 (en) | Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1 | |
MX2010012529A (en) | Phenyl and benzodioxinyl substituted indazoles derivatives. | |
WO2010150281A3 (en) | Novel azabicyclohexanes | |
WO2009093269A9 (en) | Novel heterocyclic compounds | |
MY145812A (en) | Substituted imidazoles | |
UA101835C2 (en) | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
WO2009125434A3 (en) | Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof | |
WO2007017728A3 (en) | Novel heterocyclic compounds | |
WO2006025069A8 (en) | Tricyclic pyrazole derivatives as cannabinoid receptor modulators | |
MX2010001512A (en) | Novel preparation process. | |
WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
MX2011008126A (en) | Substituted indole compounds as bradykinin receptor 1 modulators. | |
WO2010122580A3 (en) | Piperidine derivatives as inhibitors of renin | |
WO2009053999A3 (en) | Sulfoximine derivatives as factor xa inhibitors | |
ZA200804858B (en) | Sulfoximine derivatives as p38 map kinase inhibitors | |
WO2006109146A3 (en) | Novel heterocyclic derivatives | |
UA92736C2 (en) | 1h-imidazole derivatives as cannabinoid cb2 receptor modulators | |
WO2006126074A3 (en) | Heterocyclic derivatives | |
WO2007007161A3 (en) | Novel bio-active derivatives | |
WO2008062424A3 (en) | Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators | |
MY142535A (en) | Tricyclic pyrazole derivatives as cannabinoid receptor modulators | |
WO2011016050A3 (en) | Novel compounds as modulators of glucocorticoid receptors | |
UA84594C2 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives as cb1 antagonists | |
TN2010000526A1 (en) | Phenyl and benzodioxinyl substituted indazoles derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09723491 Country of ref document: EP Kind code of ref document: A2 |